glp-1 drugs for insulin resistance GLP−1 receptor agonists the treatment of obesity: Role as a promising approach GLP-1: Genetic Variants Related to

Find out everything about this - if its true and worth all the hype.

There can be side effects and risks: GLP-1 drugs affect multiple systems (pancreas, kidney, GI tract) and are not without cost or health implications

Explore natural alternatives to GLP-1 drugs like Ozempic and Mounjaro

To further note, in the field of weight-loss treatment, significant work is underway in parallel, on GIP agonist, amylin agonist, glucagon agonist, PYY agonist, either separately or in combination especially with GLP-1 agonist.

Each serving delivers 78 billion CFUs from a broad range of beneficial strains including Lactobacillus, Bifidobacterium, Akkermansia muciniphila and Christensenella minuta, known for their contribution to a balanced gut microbiome

However, renal effects of GLP-1 in heart failure (HF) has not been elucidated